Margaret S. Lee
Profile
Margaret S.
Lee worked as VP-Research & Translational Development at Karyopharm Therapeutics, Inc. and as Vice President-Research & Translational Medicine at Zalicus, Inc. She holds a doctorate degree from Sackler School of Graduate Biomedical Sciences.
Former positions of Margaret S. Lee
| Companies | Position | End |
|---|---|---|
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | - |
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Training of Margaret S. Lee
| Sackler School of Graduate Biomedical Sciences | Doctorate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Zalicus, Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company changed its name from CombinatoRx, Inc. to Zalicus, Inc. on September 8, 2010. Zalicus was founded on March 28, 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Margaret S. Lee
